No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
77 |
4. Check minimum number of eventsNone |
77 |
5. Include endpointsNone |
77 |
6. Filter based on genotype QC (FinnGen only) |
77 |
Control definitions (FinnGen only)
- Control exclude
- AB1_ARTHROPOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Other mosquito-borne viral fevers
based on the number of shared cases.
Similar with more cases:
- Arthropod-borne viral fevers and viral haemorrhagic fevers
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 699 | 362 | 335 |
| Only index persons | 635 | 339 | 296 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 46.07 | 48.04 | 43.79 |
| Only index persons | 45.47 | 47.71 | 42.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 77 | 42 | 35 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.02 |
| Median age at first event (years) | 50.08 | 48.74 | 51.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 73
- Matched controls
- 728
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A92.8
ICD-10 Finland
Other specified mosquito-borne viral fevers
+∞
55.4
46
*
A92.0
ICD-10 Finland
Chikungunya virus disease
+∞
7.4
7
*
M13.9
ICD-10 Finland
Arthritis, unspecified
8.7
7.1
15
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021788) Differential panel - Synovial fluid
6
6
10.70
3.56
1.3
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
11
6.87
3.26
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
26
143
2.24
2.61
3.7
5.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
12
5.32
2.45
1.0
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
15
4.24
2.08
2.3
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
24
139
2.06
2.07
1.4
1.7
mg/l
1.3
1.3
0.04
19
113
(40761535) Cells panel - Urine sediment
12
53
2.50
1.92
2.8
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
26
160
1.94
1.88
2.7
3.6
estimate
0.0
0.0
—
10
48
(3007164) IgA [Mass/volume] in Serum or Plasma
23
136
1.99
1.86
1.4
1.3
g/l
2.6
2.2
0.77
16
83
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
18
3.52
1.78
2.3
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
13
4.03
1.74
1.0
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.33
1.69
2.3
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
19
3.33
1.69
1.3
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
25
2.97
1.69
1.3
1.2
g/l
0.2
0.2
—
7
25
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
245
1.79
1.67
3.2
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
42
312
1.76
1.62
4.6
4.9
estimate
0.0
0.0
—
10
53
(3035350) Ketones [Presence] in Urine by Test strip
42
312
1.76
1.62
3.1
3.5
estimate
0.0
0.0
—
10
52
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
27
2.75
1.55
1.3
1.2
g/l
1.0
1.2
—
7
27
(3009261) Glucose [Presence] in Urine by Test strip
42
317
1.71
1.49
3.1
3.5
estimate
0.0
0.0
—
10
47
(3023368) Bacteria identified in Blood by Culture
25
163
1.79
1.48
3.1
4.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
22
139
1.82
1.44
1.5
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
116
1.85
1.38
1.2
1.2
iu/ml
8.1
43.0
—
5
42
(40761536) Microorganisms panel - Urine sediment
9
43
2.23
1.35
1.6
3.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
35
2.43
1.31
1.4
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
102
1.86
1.30
2.1
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
25
2.51
1.27
1.5
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
19
2.74
1.23
1.8
2.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
52
431
1.64
1.17
3.3
3.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
51
2.10
1.17
1.1
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
20
2.60
1.17
1.8
2.2
mg/l
11.5
10.7
—
5
20
(3002256) Pathology report gross observation
13
74
1.91
1.15
1.4
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
26
183
1.64
1.15
2.5
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
90
1.83
1.14
1.1
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
41
2.06
1.12
1.3
1.2
—
16.3
—
0
5
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
115
1.74
1.12
1.3
1.3
u/ml
2.1
9.0
—
6
49
(3015736) pH of Urine
33
248
1.58
1.11
3.4
3.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
22
150
1.65
1.09
1.4
1.3
u/ml
0.8
1.9
1.07
11
45
(1761868) Lipid panel - Serum or Plasma
32
240
1.57
1.08
2.1
2.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
53
2.02
1.07
3.3
3.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
34
2.16
1.06
1.7
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
16
101
1.74
1.04
2.5
3.6
ng/l
12.9
93.2
—
10
73
(3025941) Bacteria identified in Stool by Culture
7
37
1.98
0.97
1.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
29
219
1.52
0.93
2.5
3.2
e6/l
8.5
58.1
1.35
21
154
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
29
2.16
0.91
1.3
3.7
mmol/l
25.6
24.3
—
6
29
(3013512) EKG study
23
167
1.54
0.87
3.2
3.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
38
307
1.47
0.87
4.7
5.0
%
55.7
56.7
0.19
38
287
(4035726)
10
58
1.83
0.84
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
74
1.74
0.84
1.2
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
32
1.95
0.83
1.3
4.4
%
48.6
54.9
—
6
32
(42870588) Differential panel, method unspecified - Blood
26
199
1.46
0.76
7.2
5.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
7
38
1.92
0.76
1.9
2.5
g/l
63.7
66.7
—
7
33
(3019550) Sodium [Moles/volume] in Serum or Plasma
70
654
1.77
0.75
12.5
14.3
mmol/l
139.9
139.8
0.23
70
640
(3020891) Body temperature
5
25
2.07
0.74
1.2
5.5
—
—
—
0
0
(3000492) Spirometry study
10
61
1.73
0.72
1.1
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
35
286
1.41
0.72
3.5
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
52
456
1.43
0.71
3.4
3.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
27
1.91
0.70
2.2
6.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
139
1.49
0.69
3.4
3.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
87
1.59
0.68
1.2
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
168
1.43
0.65
2.0
2.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
70
659
1.68
0.64
12.7
14.2
mmol/l
4.0
4.0
0.93
70
645
(3032080) INR in Blood by Coagulation assay
28
224
1.39
0.64
8.9
4.9
inr
1.1
1.1
0.25
14
66
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
72
1.62
0.63
1.1
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
225
1.38
0.62
2.5
3.7
ng/l
22.2
37.2
0.54
16
144
(40768797) Stomach Pathology biopsy report
12
81
1.57
0.61
1.9
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
21
0.00
0.61
0.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
21
0.00
0.61
0.0
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
46
402
1.36
0.60
3.2
3.8
—
20.3
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
36
1.72
0.58
1.0
1.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
38
1.63
0.56
1.2
2.4
%
1.4
1.6
—
6
38
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
220
1.35
0.54
2.8
2.8
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
39
1.58
0.54
1.3
3.2
g/l
125.7
128.3
—
6
39
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
11
75
1.54
0.54
1.3
2.3
%
21.8
22.8
0.09
11
61
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
64
1.46
0.54
1.7
2.1
nmol/l
278.8
384.2
—
9
57
(3044889) 12 lead EKG panel
49
437
1.33
0.53
2.2
3.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
17
130
1.39
0.49
2.4
2.7
ug/l
0.6
0.7
—
9
83
(40768804) Tissue Pathology biopsy report
31
262
1.31
0.48
2.2
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
49
1.47
0.47
1.0
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
12
87
1.45
0.45
1.8
2.2
umol/l
13.3
12.9
0.08
12
76
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.65
0.44
1.8
2.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
5
32
1.60
0.43
1.0
3.7
mmol/l
1.5
1.3
—
5
27
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
38
334
1.27
0.43
3.7
6.9
umol/l
9.5
10.2
0.33
38
318
(1002224) Polysomnography panel
5
33
1.55
0.42
1.0
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
15
0.00
0.41
0.0
2.5
—
160.3
—
0
15
(40768793) Breast Pathology biopsy report
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
34
1.50
0.41
1.6
2.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
17
0.00
0.41
0.0
2.3
—
0.4
—
0
8
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
17
0.00
0.41
0.0
2.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
11
80
1.44
0.41
1.5
2.3
g/l
2.5
2.3
0.27
11
69
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
110
0.70
0.41
1.5
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
66
1.41
0.40
1.2
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
35
1.46
0.40
2.2
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
70
1.32
0.38
1.3
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
21
174
1.28
0.37
5.6
6.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
33
291
1.23
0.34
6.5
5.2
%
0.7
0.6
0.40
33
267
(3003694) ABO and Rh group [Type] in Blood
20
166
1.28
0.34
1.5
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
67
639
1.37
0.34
14.3
13.6
mg/l
23.4
24.3
0.08
58
501
(3002032) Base excess in Venous blood by calculation
7
55
1.30
0.31
1.3
3.4
mmol/l
2.0
2.4
—
7
41
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
76
1.36
0.30
1.0
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
67
642
1.34
0.29
3.4
4.1
mmol/l
4.8
4.7
0.23
60
601
(3027945) Reticulocytes/100 erythrocytes in Blood
8
62
1.32
0.29
2.3
2.3
%
1.9
1.8
—
8
53
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
72
0.67
0.27
2.2
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
75
1.23
0.26
1.1
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
58
607
0.82
0.24
12.6
13.0
%
40.7
40.0
0.25
45
488
(3012095) Magnesium [Moles/volume] in Serum or Plasma
7
90
0.76
0.24
1.6
3.8
mmol/l
0.8
0.8
—
7
82
(40761511) CBC panel - Blood by Automated count
70
677
1.37
0.24
12.5
11.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
38
1.34
0.24
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
39
360
1.17
0.23
3.6
4.4
mmol/l
6.2
6.7
1.19
39
335
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9
111
0.79
0.22
1.8
3.2
mmol/l
2.5
2.5
—
9
99
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
10
0.00
0.21
0.0
2.0
—
64.2
—
0
10
(3024928) Oxygen saturation in Venous blood
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
90
1.26
0.20
1.5
2.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.9
—
6.6
—
0
7
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
66
639
1.23
0.19
3.6
4.1
mmol/l
1.4
1.5
0.15
60
590
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
82
1.25
0.18
1.5
2.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
19
168
1.17
0.18
3.5
4.1
%
16.1
22.7
—
9
77
(3020564) Creatinine [Moles/volume] in Serum or Plasma
71
694
1.30
0.16
14.7
14.6
umol/l
74.7
76.5
0.27
71
694
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
64
622
1.17
0.14
10.1
12.0
ml/min/173m2
87.3
84.8
0.55
56
504
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
58
597
0.88
0.12
4.3
5.5
mmol/mol
38.6
39.7
0.38
52
562
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
23
248
0.90
0.11
4.5
6.1
mmol/l
1.2
1.2
0.12
23
225
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
5
43
1.17
0.10
1.8
5.4
mmol/l
1.3
1.2
—
5
43
(3044640) Blood type and Crossmatch panel - Blood
21
195
1.11
0.09
1.6
2.3
—
—
—
0
0
(3012544) pH of Venous blood
6
54
1.12
0.09
1.3
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
63
0.78
0.08
1.8
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
63
1.12
0.08
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
68
1.03
0.08
2.6
7.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13
141
0.91
0.06
1.7
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
25
241
1.06
0.03
1.4
1.8
pmol/l
86.2
90.2
0.19
13
130
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
65
658
0.92
0.03
3.8
4.5
mmol/l
3.0
2.8
1.06
59
614
(3019150) Specific gravity of Urine by Refractometry
15
143
1.06
0.01
4.5
3.5
kg/l
1.0
1.0
—
5
15
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
63
624
1.05
0.00
3.4
3.7
mmol/l
1.2
1.3
0.47
56
573
(3026008) Bacteria identified in Urine by Culture
17
172
0.99
0.00
2.2
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
135
0.96
0.00
1.1
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
115
1.05
0.00
1.5
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
95
1.06
0.00
1.2
1.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
5
54
0.92
0.00
5.4
4.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
5.4
—
26.5
—
0
8
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.3
—
946.3
—
0
6
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
8.8
—
0.7
—
0
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.4
—
51.0
—
0
5
(3000991) Gas panel - Venous blood
5
49
1.02
0.00
5.2
7.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.2
—
4.0
—
0
6
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4268621)
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.1
—
11.3
—
0
7
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
12.7
—
1717.3
—
0
6
(3007461) Platelets [#/volume] in Blood
72
720
1.00
0.00
20.6
19.0
e9/l
248.7
249.6
0.04
72
704
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
72
721
0.98
0.00
20.5
18.9
fl
90.1
91.0
0.95
72
711
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
72
721
0.98
0.00
20.6
19.0
e12/l
4.5
4.5
0.08
72
701
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
1849.0
—
0
5
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
97.3
—
0
7
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
7.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
72
721
0.98
0.00
20.4
18.9
pg
29.9
30.3
1.21
72
711
(3000963) Hemoglobin [Mass/volume] in Blood
72
721
0.98
0.00
20.5
19.1
g/l
134.3
136.9
0.82
72
710
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
8.9
—
0
5
(4146454)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
70
697
1.05
0.00
11.2
9.9
u/l
28.0
26.0
0.47
70
682
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_OTHER_MOSQUITO_FEVER and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_OTHER_MOSQUITO_FEVER.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_OTHER_MOSQUITO_FEVER – Other mosquito-borne viral fevers
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data